FOI release

Freedom of Information responses from the MHRA - week commencing 16 May 2022

皇冠体育app Medicines and Healthcare products Regulatory Agency (MHRA) responses to freedom of information (FOI) requests for week commencing 16 May 2022

From:
Medicines and Healthcare products Regulatory Agency
Published
27 March 2023

Documents

Freedom of Information request on the number of 150-day applications have been submitted (FOI 22/467)

HTML

Freedom of Information request on the clinical details of the suspected adverse reactions of lens opacities with cystic fibrosis transmembrane conductance regulator modulators (FOI /614)

HTML

PDF, 83.3 KB, 1 page

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Freedom of Information request on the COVID-19 vaccines and lateral flow tests (FOI 22/649)

HTML

Freedom of Information request on the yellow card reports submitted for ctroconvulsive 皇冠体育apprapy devices over the past 5 years

HTML

Freedom of Information request on list of all GP practices that contribute patient date to the Clinical Practice Research Datalink (FOI 22/700)

HTML

Freedom of Information request on MHRA staffing for inspectors between November 2021 and March 2022 (FOI 22/468)

HTML

Freedom of Information request on the meetings of the Opioid Expert Working Group of the Commission on Human Medicines since April 2019 (FOI 22/625)

HTML

Freedom of Information request on the adverse reactions reported for avesical Bacillus Calmette Gu茅rrin (FOI 22/628)

HTML

Freedom of Information request on the IT contracts (FOI 22/675)

HTML

Freedom of Information request on the rolling review of the Valneva COVID-19 vaccine (FOI 22/691)

HTML

Freedom of Information request on the adverse reactions reported relating to Aripiprazole (FOI 22/694)

HTML

Freedom of Information request on the number of organisations that have licensed data from CPRD from 2018-2022 (FOI 22/707)

HTML

Details

皇冠体育app Medicines and Healthcare products Regulatory Agency (MHRA) responses to freedom of information (FOI) requests for week commencing 16 May 2022

Updates to this page

Published 27 March 2023

Sign up for emails or print this page